ID: ALA600664

Max Phase: Preclinical

Molecular Formula: C16H25F2N4O4P

Molecular Weight: 406.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOP(=O)(OCC)C(F)(F)CCCCCc1c[nH]c2c(=O)[nH]c(N)nc12

Standard InChI:  InChI=1S/C16H25F2N4O4P/c1-3-25-27(24,26-4-2)16(17,18)9-7-5-6-8-11-10-20-13-12(11)21-15(19)22-14(13)23/h10,20H,3-9H2,1-2H3,(H3,19,21,22,23)

Standard InChI Key:  GYXAXLLQFNASIO-UHFFFAOYSA-N

Associated Targets(Human)

Purine nucleoside phosphorylase 774 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Purine nucleoside phosphorylase 323 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 406.37Molecular Weight (Monoisotopic): 406.1581AlogP: 3.80#Rotatable Bonds: 11
Polar Surface Area: 123.09Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.23CX Basic pKa: 4.88CX LogP: 2.31CX LogD: 2.31
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.39Np Likeness Score: 0.07

References

1. Hikishima S, Hashimoto M, Magnowska L, Bzowska A, Yokomatsu T..  (2010)  Structural-based design and synthesis of novel 9-deazaguanine derivatives having a phosphate mimic as multi-substrate analogue inhibitors for mammalian PNPs.,  18  (6): [PMID:20189401] [10.1016/j.bmc.2010.01.062]

Source